Moving forward in young adult cancer advocacy

Article

Today I learned that around 72,000 young adults are diagnosed with cancer each year. That's around one young adult diagnosed every eight minutes. These are stats I didn't know before, and I imagine many of those outside the young adult cancer movement don't know either. But what I found most fascinating is the progress the movement has made even in the last 20 years. Now, there's the LIVESTRONG Young Adult Alliance, the American Society of Clinical Ongology's "Focus under 40," many AYA-focused organizations springing up, growth of AYA-specific clinics (there are an estimated 18 in the U.S.), a new journal and society for AYA oncology and, most recently, the National Comprehensive Cancer Network released physician guidelines for adolescents and young adults.Part of these great advances for the movement is an increased visibility, not only in the cancer sphere but also with the general public. Will Reiser, screenwriter of 50/50 and a young adult cancer survivor himself, spoke to the gathered patients, survivors, caregivers and advocates. He said that when they started production on the movie, they were worried that the irreverent humor in the film would offend people and cancer organizations might not like it. Instead, he's here in Vegas talking to hundreds of people who can relate to the experiences he put on the screen. He said he went through a lot of the issues he put on the screen in different ways and that because he was an expert on a topic that no one around him really was, he was able to uniquely share that, especially conveying young adult cancer patients isolation. And even though cancer is such a personal illness, he's been able to connect with several people who also had similar experiences. And what's even more exciting is that everyone here is embracing the growing momentum of the movement. The theme of the conference is about sharing and learning from each other and looking forward so that future young adult cancer patients have a better experience--both medically and psychosocially. With the new NCCN guidelines for physicians out now, guidelines for patients will follow within the year, so young adult patients can know what questions to ask their physicians. I got the chance to talk with Brad Zebrack, PhD, himself a young adult cancer survivor and now a researcher into young adult cancer topics. As part of his next research project, he wants to ask young adult cancer survivors what would be the optimal system of care and what programs they would like to have in place. He wants to then take the voices of the survivors to the people in charge of making decisions--to add in a voice that's been missing.It's interesting to see how young adult cancer advocacy has grown, but it's exciting to see how it's still growing and where advocacy is going. What aspect of the young adult cancer movement are you excited for?

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content